rs145449046
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000492.4(CFTR):āc.2374C>Gā(p.Arg792Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 1,521,040 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R792Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.2374C>G | p.Arg792Gly | missense_variant | 14/27 | ENST00000003084.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFTR | ENST00000003084.11 | c.2374C>G | p.Arg792Gly | missense_variant | 14/27 | 1 | NM_000492.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000127 AC: 23AN: 181308Hom.: 0 AF XY: 0.000157 AC XY: 15AN XY: 95510
GnomAD4 exome AF: 0.0000241 AC: 33AN: 1368778Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 18AN XY: 671288
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152262Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74436
ClinVar
Submissions by phenotype
Cystic fibrosis Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 31, 2023 | The p.R792G variant (also known as c.2374C>G), located in coding exon 14 of the CFTR gene, results from a C to G substitution at nucleotide position 2374. The arginine at codon 792 is replaced by glycine, an amino acid with dissimilar properties. In a study of 42 men with congenital bilateral absence of the vas deferens, this variant was detected in one individual with another missense variant, p.R766M, on the other allele (Ravnik-Glavac M et al. Hum. Hered.;50:318-9). In vitro studies demonstrated that the variant significantly reduces chloride current and open probabilities of the channel, but still retains approximately 50% of channel activity (Vankeerberghen A et al. Hum. Mol. Genet., 1998 Oct;7:1761-9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Oct 05, 2022 | This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 792 of the CFTR protein (p.Arg792Gly). This variant is present in population databases (rs145449046, gnomAD 0.09%). This missense change has been observed in individual(s) with CFTR-related conditions (PMID: 9736778). ClinVar contains an entry for this variant (Variation ID: 35840). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CFTR protein function. Experimental studies have shown that this missense change affects CFTR function (PMID: 9736778). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 10, 2019 | The CFTR c.2374C>G; p.Arg792Gly variant (rs145449046) has been described in the compound heterozygous state in one individual with congenital bilateral absence of the vas deferens (Ravnik-Glavac 2000). It is reported as a variant of uncertain significance in ClinVar (Variation ID: 35840) and observed in the Latino population at an overall frequency of 0.095% (21/22002 alleles) in the Genome Aggregation Database. The arginine at codon 792 is highly conserved, and computational algorithms (SIFT, PolyPhen-2) predict that this variant is deleterious. In vitro functional studies of the variant protein demonstrate reduced chloride current and disruption of a consensus recognition site used for CFTR activation (Vankeerberghen 1998). However, due to limited clinical information regarding this variant, its clinical significance cannot be determined with certainty. References: Ravnik-Glavac M et al. Two novel missense mutations (R766M and R792G) in exon 13 of the CFTR gene in a patient with congenital bilateral absence of the vas deferens. Hum Hered. 2000 Sep-Oct;50(5):318-9. Vankeerberghen A et al. Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. Hum Mol Genet. 1998 Oct;7(11):1761-9. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 28, 2023 | Variant summary: CFTR c.2374C>G (p.Arg792Gly) results in a non-conservative amino acid change located in the CFTR regulator domain (IPR025837) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00013 in 181538 control chromosomes, predominantly at a frequency of 0.00095 within the Latino subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in CFTR causing Congenital Bilateral Absence Of The Vas Deferens or Cystic Fibrosis, allowing no conclusion about variant significance. c.2374C>G has been reported in the literature in individuals affected with Congenital Bilateral Absence Of The Vas Deferens and Cystic Fibrosis and has been subsequently cited by others (example, Vankeerberghen_1998, Ravnik-Glavac_2000, Dorfman_2010, Green_2010, Rowntree_2003, de Souza_2018, Yang_2015). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 30%-50% of normal activity for whole cell chloride currents measured in Xenopus laevis oocytes (Vakneerberghen_1998). The following publications have been ascertained in the context of this evaluation (PMID: 20059485, 20932301, 25735457, 10878476, 12940920, 9736778, 26277102, 29216686). Nine submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 12, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 22, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 29216686, 20932301, 9736778, 12940920, 26277102, 10878476) - |
Hereditary pancreatitis Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | May 04, 2021 | - - |
Cystic fibrosis;C0238339:Hereditary pancreatitis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation;C2749757:Bronchiectasis with or without elevated sweat chloride 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 09, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at